Current status and outlook of biodegradable metals in neuroscience and their potential applications as cerebral vascular stent materials
Source abstract
Abstract
Over the past two decades, biodegradable metals (BMs) have emerged as promising materials to fabricate temporary biomedical devices, with the purpose of avoiding potential side effects of permanent implants. In this review, we first surveyed the current status of BMs in neuroscience, and briefly summarized the representative stents for treating vascular stenosis. Then, inspired by the convincing clinical evidence on the in vivo safety of Mg alloys as cardiovascular stents, we analyzed the possibility of producing biodegradable cerebrovascular Mg alloy stents for treating ischemic stroke. For these novel applications, some key factors should also be considered in designing BM brain stents, including the anatomic features of the cerebral vasculature, hemodynamic influences, neuro-cytocompatibility and selection of alloying elements. This work may provide insights into the future design and fabrication of BM neurological devices, especially for brain stents.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Nanoporous metals and alloys · Corrosion Behavior and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Biodegradable magnesium alloys promote angio-osteogenesis to enhance bone repair10.1002/advs.202000800 ↗
2. Controlling the dissolution of iron through the development of nanostructured Fe-Mg for biomedical applications10.1016/j.actbio.2020.06.014 ↗
3. Long-term in vivo study of biodegradable Zn-Cu stent: a 2-year implantation evaluation in porcine coronary artery10.1016/j.actbio.2019.08.012 ↗
4. Biodegradable inorganic nanostructured biomaterials for drug delivery10.1002/admi.202000819 ↗
5. Recent research and progress of biodegradable zinc alloys and composites for biomedical applications: biomechanical and biocorrosion perspectives10.1016/j.bioactmat.2020.09.013 ↗
6. Additively manufactured biodegradable porous metals10.1016/j.actbio.2020.08.018 ↗
7. Biodegradable materials for bone defect repair10.1186/s40779-020-00280-6 ↗
8. Donkor · 2018
9. Endovascular metal devices for the treatment of cerebrovascular diseases
10. Risk factors associated with major cerebrovascular complications after intracranial stenting10.1212/01.wnl.0b013e3181a1863c ↗
11. A greater focus on metals in biomedicine and neuroscience is needed10.1186/s40360-016-0095-4 ↗
12. Biodegradable stents for coronary artery disease treatment: recent advances and future perspectives, Materials science & engineering
13. Bioresorbable silicon electronic sensors for the brain10.1038/nature16492 ↗
14. Flexible, sticky, and biodegradable wireless device for drug delivery to brain tumors10.1038/s41467-019-13198-y ↗
15. Bioresorbable optical sensor systems for monitoring of intracranial pressure and temperature10.1126/sciadv.aaw1899 ↗
16. Bioresorbable electrode array for electrophysiological and pressure signal recording in the brain10.1002/adhm.201801649 ↗
17. Advanced materials and devices for bioresorbable electronics10.1021/acs.accounts.7b00548 ↗
18. Recent progress on biodegradable materials and transient electronics10.1016/j.bioactmat.2017.12.001 ↗
19. Dissolvable metals for transient electronics10.1002/adfm.201301847 ↗
20. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
21. Bioresorbable metals in cardiovascular stents: material insights and progress10.1016/j.mtla.2020.100727 ↗
22. Challenges in the use of zinc and its alloys as biodegradable metals: perspective from biomechanical compatibility10.1016/j.actbio.2019.07.038 ↗
23. Current status and outlook on the clinical translation of biodegradable metals10.1016/j.mattod.2018.05.018 ↗
24. Research status of biodegradable metals designed for oral and maxillofacial applications: a review10.1016/j.bioactmat.2021.01.011 ↗
25. The current trends of Mg alloys in biomedical applications—a review10.1002/jbm.b.34290 ↗
26. Advances in functionalized polymer coatings on biodegradable magnesium alloys - a review10.1016/j.actbio.2018.08.030 ↗
27. Dose optimization of intravenous magnesium sulfate after acute stroke10.1161/01.STR.29.5.918 ↗
28. Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia10.1016/S1010-7940(98)00140-7 ↗
29. Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage10.1177/1933719107305864 ↗
30. Magnesium treatment for neuroprotection in ischemic diseases of the brain
31. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia10.1016/j.brainres.2004.03.073 ↗
32. A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery10.1098/rsif.2011.0438 ↗
33. The current trends of Mg alloys in biomedical applications-A review10.1002/jbm.b.34290 ↗
34. Over the horizon: the present and future of endovascular neural recording and stimulation10.3389/fnins.2020.00432 ↗
35. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy10.1016/j.injury.2010.12.030 ↗
36. Futuristic medical implants using bioresorbable materials and devices10.1016/j.bios.2019.111489 ↗
37. Testing bioresorbable stent feasibility in a rat aneurysm model10.1136/neurintsurg-2018-014697 ↗
38. Magnesium alloy covered stent for treatment of a lateral aneurysm model in rabbit common carotid artery: an in vivo study10.1038/srep37401 ↗
39. Fabrication of tannic acid/poly(N-vinylpyrrolidone) layer-by-layer coating on Mg-based metallic glass for nerve tissue regeneration application10.1016/j.colsurfb.2018.06.060 ↗
40. Initial observations on using magnesium metal in peripheral nerve repair10.1177/0885328214553135 ↗
41. Short and long gap peripheral nerve repair with magnesium metal filaments10.1002/jbm.a.36176 ↗
42. Biocompatibility and neurotoxicity of magnesium alloys potentially used for neural repairs, Materials science & engineering10.1016/j.msec.2017.04.106 ↗
43. Hydroxyapatite coated magnesium alloy for peripheral nerve regeneration10.21851/obr.42.03.201809.105 ↗
44. Recent development of implantable and flexible nerve electrodes10.1016/j.smaim.2020.08.002 ↗
45. Progress in research of flexible MEMS microelectrodes for neural interface10.3390/mi8090281 ↗
46. Chronic neural recording with probes of subcellular cross-section using 0.06 mm2 dissolving microneedles as insertion device10.1016/j.snb.2018.12.030 ↗
47. A new process for fabricating tip-shaped polymer microstructure array with patterned metallic coatings10.1016/j.sna.2009.01.009 ↗
48. Electrochemical deposition of conductive polymers onto magnesium microwires for neural electrode applications10.1002/jbm.a.36385 ↗
49. Fabrication and characterization of biodegradable metal based microelectrodes for in vivo neural recording10.1557/adv.2019.302 ↗
50. Stenting for acute carotid artery dissection10.1161/STROKEAHA.119.027827 ↗
51. Stent design, restenosis and recurrent stroke after carotid artery stenting in the international carotid stenting study10.1161/STROKEAHA.118.024076 ↗
52. Biodegradable magnesium stent treatment of saccular aneurysms in a rat model - introduction of the surgical technique
53. The degradation and transport mechanism of a Mg-Nd-Zn-Zr stent in rabbit common carotid artery: a 20-month study10.1016/j.actbio.2018.01.018 ↗
54. Iron and alzheimer's disease: an update on emerging mechanisms10.3233/JAD-179944 ↗
55. Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE10.1038/ncomms7760 ↗
56. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications10.1016/j.addr.2019.01.005 ↗
57. Fe and Fe-P foam for biodegradable bone replacement material: morphology, corrosion behaviour, and mechanical properties
58. Lili, Study on a biodegradable antibacterial Fe-Mn-C-Cu alloy as urinary implant material10.1016/j.msec.2019.05.003 ↗
59. Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron10.1016/j.actbio.2010.11.001 ↗
60. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal—results 6–18 months after implantation into New Zealand white rabbits10.1136/heart.86.5.563 ↗
61. Are Fe-based stenting materials biocompatible? A critical review of in vitro and in vivo studies10.3390/jfb11010002 ↗
62. Preclinical evaluation of a novel sirolimus-eluting iron bioresorbable coronary scaffold in porcine coronary artery at 6 months10.1016/j.jcin.2018.10.020 ↗
63. Strategy of metal-polymer composite stent to accelerate biodegradation of iron-based biomaterials10.1021/acsami.7b15206 ↗
64. Long-term in vivo corrosion behavior, biocompatibility and bioresorption mechanism of a bioresorbable nitrided iron scaffold10.1016/j.actbio.2017.03.020 ↗
65. PDLLA-Zn-nitrided Fe bioresorbable scaffold with 53-μm-thick metallic struts and tunable multistage biodegradation function10.1126/sciadv.abf0614 ↗
66. A fully biodegradable and self-electrified device for neuroregenerative medicine10.1126/sciadv.abc6686 ↗
67. The interaction of zinc and the blood-brain barrier under physiological and ischemic conditions10.1016/j.taap.2018.12.018 ↗
68. The biochemical basis of zinc physiology10.1152/physrev.1993.73.1.79 ↗
69. Neurological impact of zinc excess and deficiency in vivo10.9734/EJNFS/2017/35783 ↗
70. Depletion of serum zinc in ischemic stroke patients10.1358/mf.2010.32.6.1487084 ↗
71. Rationally designed protein cross-linked hydrogel for bone regeneration via synergistic release of magnesium and zinc ions10.1016/j.biomaterials.2021.120895 ↗
72. Biodegradable Zn-Sr alloy for bone regeneration in rat femoral condyle defect model: in vitro and in vivo studies10.1016/j.bioactmat.2020.11.007 ↗
73. Fabrication of magnesium/zinc-metal organic framework on titanium implants to inhibit bacterial infection and promote bone regeneration10.1016/j.biomaterials.2019.05.008 ↗
74. Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model10.1016/j.biomaterials.2017.08.022 ↗
75. Zn-Mg and Zn-Cu alloys for stenting applications: from nanoscale mechanical characterization to in vitro degradation and biocompatibility10.1016/j.bioactmat.2021.04.015 ↗
76. Zinc-based alloys for degradable vascular stent applications10.1016/j.actbio.2018.03.005 ↗
77. Evolution of metallic cardiovascular stent materials: a comparative study among stainless steel, magnesium and zinc10.1016/j.biomaterials.2019.119641 ↗
78. Corrosion behavior of biodegradable metals in two different simulated physiological solutions: comparison of Mg, Zn and Fe10.1016/j.corsci.2021.109278 ↗
79. Aghion · Biodegradable Metals, Metals · 2018 · 8
80. Advances in biomaterials and technologies for vascular embolization
81. Opacification of shape memory polymer foam designed for treatment of intracranial aneurysms10.1007/s10439-011-0468-1 ↗
82. Degradation of tungsten coils implanted into the subclavian artery of New Zealand white rabbits is not associated with local or systemic toxicity10.1016/S0142-9612(02)00352-6 ↗
83. Corrosion of tungsten microelectrodes used in neural recording applications10.1016/j.jneumeth.2011.03.012 ↗
84. A perspective on molybdenum biocompatibility and antimicrobial activity for applications in implants10.1007/s10853-015-9664-y ↗
85. Molybdenum – a biodegradable implant material for structural applications?10.1016/j.actbio.2019.12.031 ↗
86. Recent advances in biodegradable metals for medical sutures: a critical review10.1002/adhm.201500189 ↗
87. Bioresorbable stents: current and upcoming bioresorbable technologies10.1016/j.ijcard.2016.11.258 ↗
88. Recent insights from scanning electron microscopic assessment of durable polymer-coated drug-eluting stents10.2217/ica.12.67 ↗
89. Cobalt-chromium KAname coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study)10.1111/joic.12144 ↗
90. Safety and efficacy of the new micromesh-covered stent CGuard in patients undergoing carotid artery stenting: early experience from a single centre10.1016/j.ejvs.2017.09.015 ↗
91. Bioresorbable scaffolds: rationale, current status, challenges, and future10.1093/eurheartj/eht542 ↗
92. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results
93. Biodegradable metals for cardiovascular stent application: interests and new opportunities10.3390/ijms12074250 ↗
94. The evolving paradigm in the management of intracranial atherosclerotic disease10.1155/2012/289852 ↗
95. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study10.1161/01.CIR.83.1.148 ↗
96. First-in-man implantation of a new hybrid carotid stent to prevent periprocedural neurological events during carotid artery stenting10.1583/14-4735R.1 ↗
97. Acute occlusions of dual-layer carotid stents after endovascular emergency treatment of tandem lesions10.1161/STROKEAHA.116.015965 ↗
98. Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial10.4244/EIJV12I10A209 ↗
99. Cardiovascular stents: a review of past, current, and emerging devices10.3390/ma14102498 ↗
100. Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: igaki-Tamai stents10.1161/CIRCULATIONAHA.110.000901 ↗